Profil Institute Closes Nearly 200 Clinical Trials on Diabetes and Obesity

Profil Institute Closes Nearly 200 Clinical Trials on Diabetes and Obesity

diabetes news journalBy: Leonor Mateus Ferreiraby
The early phase clinical research organization Profil Institute for Clinical Research announced the completion of more than 200 phase I to IIa clinical trials focused on diabetes and obesity, with the purpose of assessing significant drugs for the treatment of both type 1 and 2 diabetes.

Read Full Article at Diabetes News Journal »